Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Sema4, |
RCV002257387 | SCV002531945 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-07-01 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257387 | SCV004052553 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-10 | criteria provided, single submitter | clinical testing | The p.S2810R variant (also known as c.8428A>C), located in coding exon 18 of the BRCA2 gene, results from an A to C substitution at nucleotide position 8428. The serine at codon 2810 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Breast Cancer Information Core |
RCV000113929 | SCV000147360 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2010-12-17 | no assertion criteria provided | clinical testing |